In Brief This Week: Qiagen; Danaher; ArcherDX; and More | GenomeWeb

NEW YORK (GenomeWeb) – Qiagen said this week that it will be begin offering a quality control set and verification data with its GeneReader NGS System. The company will integrate Horizon Discovery Group's industry-standard reference control data set into the GeneReader NGS workflow. Further, Qiagen said its GeneRead QIAact Actionable Insights Tumor Panel has demonstrated accuracy, consistency, and reliability in testing compared with Horizon's control data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.